Hairy Cell Leukemia Treatment - National Cancer Institute

Skip to content

NCI Home

Cancer Topics

Clinical Trials

Cancer Statistics

Research & Funding

News

About NCI


	Hairy Cell Leukemia Treatment (PDQ®)

Patient Version

Health Professional Version

En español

Last Modified: 08/01/2008


General Information About Hairy Cell Leukemia


Stages of Hairy Cell Leukemia


		Relapsed or Refractory Hairy Cell Leukemia


Treatment Option Overview


Treatment Options for Hairy Cell Leukemia


To Learn More About Hairy Cell Leukemia


Get More Information From NCI


Changes to This Summary (08/01/2008)


About PDQ

Page Options

Print This Page

Print This Document

View Entire Document

E-Mail This Document

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	The Cancer Genome Atlas Reports Brain Tumors Study New Study of Targeted Therapies for Breast Cancer The Nation's Investment in Cancer Research FY 2009 Cancer Trends Progress Report: 2007 Update Past Highlights

Relapsed or Refractory Hairy Cell Leukemia

Relapsed hairy cell leukemia has come back after treatment. Refractory hairy cell leukemia has not responded to treatment.

< Previous Section | Next Section >

| | | | | | | |

A Service of the National Cancer Institute